Great West Life Assurance CO Bei Gene, Ltd. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,252 shares of BGNE stock, worth $3.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,252
Previous 17,018 1.38%
Holding current value
$3.28 Million
Previous $2.43 Million 59.65%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$143.93 - $224.51 $33,679 - $52,535
234 Added 1.38%
17,252 $3.88 Million
Q2 2024

Aug 12, 2024
SELL
$129.52 - $174.32 $1.46 Million - $1.97 Million
-11,286 Reduced 39.87%
17,018 $2.43 Million
Q1 2024

May 13, 2024
BUY
$141.8 - $181.47 $181,787 - $232,644
1,282 Added 4.74%
28,304 $4.42 Million
Q4 2023

Feb 13, 2024
SELL
$158.67 - $201.58 $47.2 Million - $60 Million
-297,694 Reduced 91.68%
27,022 $4.84 Million
Q3 2023

Nov 14, 2023
BUY
$179.87 - $225.13 $49.1 Million - $61.5 Million
273,087 Added 528.94%
324,716 $8.33 Million
Q2 2023

Aug 10, 2023
SELL
$178.3 - $266.78 $245,519 - $367,356
-1,377 Reduced 2.6%
51,629 $9.23 Million
Q1 2023

May 12, 2023
SELL
$215.53 - $274.5 $6.16 Million - $7.85 Million
-28,600 Reduced 35.05%
53,006 $11.4 Million
Q4 2022

Feb 10, 2023
BUY
$125.51 - $229.3 $1.48 Million - $2.71 Million
11,800 Added 16.9%
81,606 $18 Million
Q3 2022

Nov 01, 2022
BUY
$131.8 - $202.24 $9.2 Million - $14.1 Million
69,806 New
69,806 $9.41 Million
Q2 2022

Aug 09, 2022
SELL
$121.11 - $216.05 $133,221 - $237,655
-1,100 Reduced 1.61%
67,106 $10.9 Million
Q1 2022

May 12, 2022
BUY
$146.52 - $269.56 $849,816 - $1.56 Million
5,800 Added 9.29%
68,206 $13.4 Million
Q4 2021

Feb 14, 2022
SELL
$248.56 - $389.34 $769,044 - $1.2 Million
-3,094 Reduced 4.72%
62,406 $16.8 Million
Q3 2021

Nov 15, 2021
BUY
$249.6 - $403.14 $1.8 Million - $2.9 Million
7,200 Added 12.35%
65,500 $23.9 Million
Q2 2021

Aug 11, 2021
BUY
$292.75 - $367.01 $2.11 Million - $2.64 Million
7,200 Added 14.09%
58,300 $20 Million
Q1 2021

May 17, 2021
BUY
$260.64 - $382.12 $1.09 Million - $1.6 Million
4,200 Added 8.96%
51,100 $17.7 Million
Q4 2020

Feb 16, 2021
BUY
$221.31 - $316.61 $5.98 Million - $8.55 Million
27,000 Added 135.68%
46,900 $12.1 Million
Q3 2020

Nov 13, 2020
BUY
$189.18 - $286.44 $227,016 - $343,728
1,200 Added 6.42%
19,900 $5.7 Million
Q2 2020

Aug 17, 2020
SELL
$123.9 - $195.41 $148,680 - $234,492
-1,200 Reduced 6.03%
18,700 $3.51 Million
Q1 2020

May 14, 2020
BUY
$121.84 - $173.19 $12,184 - $17,319
100 Added 0.51%
19,900 $2.47 Million
Q4 2019

Feb 11, 2020
SELL
$115.78 - $208.34 $312,606 - $562,518
-2,700 Reduced 12.0%
19,800 $3.28 Million
Q3 2019

Oct 25, 2019
BUY
$120.61 - $148.29 $253,281 - $311,409
2,100 Added 10.29%
22,500 $2.76 Million
Q2 2019

Jul 31, 2019
BUY
$113.99 - $146.86 $450,146 - $579,950
3,949 Added 24.0%
20,400 $0
Q1 2019

May 08, 2019
BUY
$122.82 - $151.83 $921,150 - $1.14 Million
7,500 Added 83.79%
16,451 $2.17 Million
Q4 2018

Feb 12, 2019
BUY
$107.01 - $175.15 $957,846 - $1.57 Million
8,951 New
8,951 $1.21 Million

Others Institutions Holding BGNE

# of Institutions
252
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $19.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email